4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-103533
CEO & President bought 32,000 shares at an average $33.04 ($1,057,216)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox John CEO & President | 2024-09-04 | Purchase | +800 | $32.57 | $26,056 | 800 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +7,200 | $33.09 | $238,248 | 8,000 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +800 | $32.57 | $26,056 | 800 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +7,200 | $33.09 | $238,248 | 8,000 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +800 | $32.57 | $26,056 | 800 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +7,200 | $33.09 | $238,248 | 8,000 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +800 | $32.57 | $26,056 | 800 | I |
| Cox John CEO & President | 2024-09-04 | Purchase | +7,200 | $33.09 | $238,248 | 8,000 | I |
| Open-market purchases · 32,000 sh · avg $33.04 · $1,057,216 | |||||||
Loading xslF345X05/ownership.xml…